This has been one of the two main knocks on this company, and I couldn't agree with you more. The other knock is having a doctor as a CEO, instead of a traditional, business minded CEO. I like the company, the product, and even Dr. Shane, although they could use someone business minded. From what I can tell, Dr. Shane is serious about growing the company. However, he does not seem to be concerned with shareholder value, and fluctuations in stock price. A good CEO needs to be able to grow the company as well as maintain shareholder value. There is no reason that this company should be trading where it is now.
IMO, the confusion with Dr. Shane on the 1st quarter conference call, and the amount of revenue booked halfway through the 2nd quarter is the main reason why the pps is where it is. I still can't understand how, with the numbers just reported for Q2, we are sitting around .24 lower than after the Q1 call. It just doesn't make sense, and I know eventually the price will reflect the true worth of this awesome company.
GLTA! TOMZ
News 
Market Data 
Discover 
AI
